Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
Derrick Y TamThin X VoHarindra C WijeysunderaDanny DvirJan O FriedrichStephen E FremesPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
Despite higher predicted surgical risk of ViV patients, there was no difference in mortality but less permanent pacemaker implantation and dialysis compared to redo SAVR. Choice of treatment must be individualized for both anatomical and patient risk factors; in high risk patients with favorable previous prosthesis size, valve-in-valve may be preferred.
Keyphrases
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- ejection fraction
- end stage renal disease
- risk factors
- chronic kidney disease
- peritoneal dialysis
- newly diagnosed
- mitral valve
- left ventricular
- cardiovascular disease
- case report
- replacement therapy
- vena cava